Skip to main content
. 2022 Mar 29;322(6):R467–R485. doi: 10.1152/ajpregu.00017.2022

Table 1.

Tissue masses after 3 wk of DOCA-salt or sham treatment

End Point 5L0D
(n = 8, 8)
2920x
(n = 8, 8)
7913
(n = 8, 8)
P Value
Diet DOCA Diet × DOCA
Body mass, g
 Sham 25.9 ± 0.3 26.3 ± 0.5 24.6 ± 0.4 <0.01 0.52 <0.01
 DOCA-salt 24.2 ± 0.3 26.2 ± 0.5 25.8 ± 0.4
Interscapular fat, mg
 Sham 63 ± 8 83 ± 19 61 ± 3 0.15 0.07 0.11
 DOCA-salt 67 ± 6 85 ± 5 b 99 ± 7a,b
Perigonadal fat, mg
 Sham 232 ± 27 376 ± 53 331 ± 19 <0.01 <0.01 0.45
 DOCA-salt 330 ± 24 525 ± 50b 523 ± 28
Perirenal fat, mg
 Sham 50 ± 2 93 ± 14 76 ± 9 <0.01 <0.01 0.97
 DOCA-salt 85 ± 9 129 ± 13 116 ± 6
Inguinal fat, mg
 Sham 151 ± 30 184 ± 29 142 ± 9 0.12 <0.01 0.08
 DOCA-salt 167 ± 12 209 ± 14 237 ± 11a
Liver, g
 Sham 1.05 ± 0.12 1.10 ± 0.08 1.12 ± 0.03 <0.01 <0.01 0.03
 DOCA-salt 1.27 ± 0.13 1.79 ± 0.08a,b 1.70 ± 0.03a,b
Heart ventricles, mg
 Sham 106 ± 4 116 ± 3 94 ± 3c <0.01 0.59 <0.01
 DOCA-salt 103 ± 2 106 ± 2 103 ± 4
Adrenal glands, mg
 Sham 4.2 ± 0.3 3.3 ± 0.3 2.8 ± 0.5 0.04 0.11 0.41
 DOCA-salt 2.9 ± 0.6 2.6 ± 0.4 2.6 ± 0.2
Kidneys, mg
 Sham 335 ± 8 335 ± 7 300 ± 9 0.14 <0.01 0.04
 DOCA-salt 415 ± 11a 436 ± 10a,b 432 ± 11 a
Spleen, mg
 Sham 61 ± 3 69 ± 5 57 ± 3 <0.01 <0.01 0.09
 DOCA-salt 45 ± 1a 59 ± 2b 55 ± 2
Tibia, cm
 Sham 1.91 ± 0.06 1.88 ± 0.05 1.79 ± 0.04 0.85 0.12 0.18
 DOCA-salt 1.80 ± 0.07 1.96 ± 0.04 1.84 ± 0.05

Data are presented as means ± SE. Data analyzed by two-way repeated-measures ANOVA. aP < 0.05 vs. diet-matched sham, bP < 0.05 vs. 5L0D + DOCA, and cP < 0.05 vs. 2920-sham by Tukey’s multiple comparison procedure. DOCA, deoxycorticosterone acetate.